头颈部癌患者治疗前中性粒细胞与淋巴细胞比值的最佳截断值:荟萃分析和验证研究。
Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study.
机构信息
Department of Otorhinolaryngology-Head and Neck Surgery, Inje University Ilsan Paik Hospital, Inje University School of Medicine, Goyang, Republic of Korea.
Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea.
出版信息
BMC Cancer. 2018 Oct 11;18(1):969. doi: 10.1186/s12885-018-4876-6.
BACKGROUND
The prognostic role of neutrophil-to-lymphocyte ratio (NLR) has been proposed in head and neck squamous cell carcinoma (HNSCC). However, it is currently unclear which cutoff values of NLR could consistently and independently differentiate HNSCC patients to better and worse prognosis groups.
METHODS
We performed a meta-analysis of prognostic significance of pretreatment NLR values, using data extracted from 24 relevant articles. Main outcomes were overall survival (OS) and disease-free survival (DFS) in HNSCC patients. Pooled hazard ratio (HR) and 95% confidence intervals (95%CI) were calculated using the random effect model for outcomes. Impacts of NLR cutoff values across the studies were assessed with a meta-regression analysis. Results were validated using an independent data set of patients (n = 540).
RESULTS
Pretreatment high NLR values above the cutoff were significantly associated with shorter OS (HR = 1.96, 95%CI = 1.66-2.31) and DFS (HR = 1.90, 95%CI = 1.41-2.54). Of note, NLR cutoffs ranging from 1.9 to 6.0 did not affect HR of OS or DFS in meta-regression analyses. In an independent cohort, any NLR cutoff between 2 and 6 produced significant HR of OS, similarly. Instead of binary cutoffs, three subgroups of NLR (< 2, 2 to 6, and ≥ 6) showed significant differences of OS in survival analyses.
CONCLUSIONS
Meta-analyses confirmed that pretreatment NLR values above the cutoff were associated with shorter survival in HNSCC patients. However, the binary cutoffs of NLR values were variable across studies. Rather, pretreatment NLR values below 2 and above 6 using a three-tier classification (< 2, 2 to 6, and ≥ 6) could consistently imply better and worse prognosis in HNSCC patients, which could be readily translated to clinics.
背景
中性粒细胞与淋巴细胞比值(NLR)的预后作用已在头颈部鳞状细胞癌(HNSCC)中提出。然而,目前尚不清楚 NLR 的最佳截断值能够一致且独立地区分 HNSCC 患者预后更好和更差的分组。
方法
我们对 24 篇相关文章中提取的数据进行了 NLR 术前预后意义的荟萃分析。主要结局为 HNSCC 患者的总生存(OS)和无病生存(DFS)。使用随机效应模型计算汇总风险比(HR)和 95%置信区间(95%CI)。通过荟萃回归分析评估 NLR 截断值在研究中的影响。使用患者的独立数据集(n=540)验证结果。
结果
术前 NLR 值高于截断值与较短的 OS(HR=1.96,95%CI=1.66-2.31)和 DFS(HR=1.90,95%CI=1.41-2.54)显著相关。值得注意的是,在荟萃回归分析中,NLR 截断值在 1.9 到 6.0 之间变化并不影响 OS 或 DFS 的 HR。在一个独立队列中,NLR 截断值在 2 到 6 之间的任何值都产生了显著的 OS HR。同样,与二元截断值相比,NLR(<2、2 到 6 和≥6)的三个亚组在生存分析中显示出 OS 的显著差异。
结论
荟萃分析证实,术前 NLR 值高于截断值与 HNSCC 患者的生存时间较短相关。然而,NLR 值的二元截断值在不同研究中存在差异。相反,使用三分位数分类(<2、2 到 6 和≥6)的 NLR 值在 2 以下和 6 以上可以一致地暗示 HNSCC 患者的预后更好和更差,这可以很容易地转化为临床应用。